Final Flashcards

1
Q

Cummins Occupational Health serves how many people in the US

A

54K (22k in southeastern Indiana

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cummins’ onsite pharmacist’s impact on drug adherence

A

Increased adherence through therapy classes (Diabetes, HTN, Cholesterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

% of adult diabetics in US that had A1c > 8% in 2020

A

27.8%. (not at Cummins though they have 96% of patients with A1c <8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cummins’ pharmacist performs high-cost claim intervention

A

$422,127 in client savings just switching metformin prescriptions to less expensive formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Benefit design impacts

A

Modulating patients’ benefits plans to save them money and keep them in better health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Brian Musial

A

VP of Pharmacy at McLaren group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Population Health Services Organization (PHSO)

A

an optimized, physician partnered operations entity that powers a system to improve health outcomes, promote economics of scale and coordination and reduce variation across the continuum.
allows healthcare organizations to purchase shared services under value-based payment arrangement (supports population risk management)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Population health; analyzed factors

A

star ratings measures, HEDIS measures, national guidelines, standards of care, other evidence-based interventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacy team at McLaren (PHSO)

A

VP of Pharmacy Data analysis= Brian Musial
5 pharmacists
1 RN, 8 Pharm Techs, 3 Data Analysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

46brooklyn

A

drug analytics, historical data, Medicaid data, NADAC, WAC. Tells us the Medicaid spend etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Supply chain

A

Manufacturer–> wholesaler –> Pharmacies–> patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ASP

A

average sales price

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Specialty use in the past 3 years (according to Brian Musial)

A

51% of spending (highest growth in immunology, endocrinology and oncology)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effect of COVID on diagnosis visits in 2020

A

almost 1 billion (967 M) diagnosis visits that did not happen. leads to less prescription utilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Common health insurance misconceptions

A

health insurance doesn’t cover all medical expenses, employers typically pay 25-30% of total annual salary for benefits, people need health insurance because health care is expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define a self insured health care plan

A

Employer assumes risk of providing health coverage for insured events. Employer acts as own insurer, claims processed by insurance company

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Benefits of self insured plans

A

Control and flexibility (avoid state-mandated benefits and control over providers), potential for decrease cost (avoid state health insurance premium taxes and other fees)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

List strategies to decrease short term health care costs

A

change insurance plans (tier and deductibles etc.), encouraged consumerism, wellness campaign (incentivize improving wellness outcomes)

19
Q

List strategies to decrease long term health care costs

A

develop metrics/brand/identity (awareness)
share stories, education, partner with local providers, create penalties and rewards (engagement/ accountability)
evaluate outcomes, add new incentives (Improvement and maintenance)

20
Q

Identify and stratify perspective populations used providing healthcare via the VA

A

Veterans, and those with service connected disabilities

21
Q

Nikola Markoski

A

Pharmacy manager analytics and clinical insights

22
Q

Supply Chain Definition

A

Network between a company and its suppliers to produce and distribute a specific product to the final buyer, interconnect journey that materials take before they are sold to customers, a system of organizations, people, activities, information and resources that provide products or services to consumers.

23
Q

4 primary pharmaceutical spend categories

A

Generic injectables, generic non-injectables, branded non contract, branded contract

24
Q

Group purchasing organizations (GPO)

A

aggregate and leverage purchase volume to negotiate discounts with manufacturers (never take possession of the product). leverages data

25
Q

Types of supply chain analytics

A

descriptive, diagnostic, predictive, prescriptive

26
Q

Causes of drug shortages

A

unknown would not provide (60%), supply demand (14%), manufacturing (12%), business decision (12%), raw material issue (2%)

27
Q

how climate change may impact healthcare and population health

A

increased heat related illnesses, worsening of air quality, spread of vector borne disease, waterborne disease, food insecurity and malnutrition, mental health impacts, increased allergies and infectious disease, healthcare system strain, displacement and migration, social inequities

28
Q

describe which populations and sectors of healthcare might be impacted the greatest by changes in the climate

A

those with high exposure (low income population, occupational groups, people in certain locations), people who are more sensitive (pregnant women, pre existing medical conditions, children), those without the ability to adapt (older adults, people with disabilities, indigenous people)

29
Q

describe the role of the pharmacist and other healthcare professionals in preventing and combating the impact of climate change on the patients we serve

A

encourage healthy lifestyles and prescribing, avoiding unneeded meds, encouraging green manufacturing, minimize waste, critically evaluate disposal of unused product, consider changes to expiration dates and recycling of medication, advocate for leaders to develop an environmentally sustainable HC system, review personal practices)

30
Q

describe the role of individual citizens in helping minimize the impact of climate change

A

MAKE THE RIGHT THING TO DO THE EASY THING TO DO, just like healthcare there will be winners and losers, long term solutions in a short term world, advocate for national standards, and incentives

31
Q

Overview of rare diseases

A

rare disease is <200,000

32
Q

ways to incentivize research and development in areas with high unmet needs

A

The Orphan Drug Act (1983), tax incentive, Public private partnership, advanced market commitments, regulatory incentives, prize fund

33
Q

review unique challenges providing high quality care for people living with rare diseases

A

many rare diseases result in premature death of infants and young children, disjointed/ uncoordinated healthcare system, specialty care, limited resources, expensive therapies, not a priority for healthcare entities, limited quality data

34
Q

describe the role of specialty pharmacy in healthcare

A

32K+ specialty Rx in US, market value is $68.3 billion, forecasted $1.5 trillion in 2033

35
Q

Specialty Medication

A

meds for small populations, medications for rare diseases, high cost medications, special handling requirements, not just injectables, reimbursement challenges

36
Q

describe where specialty pharmacies fit into the drug supply chain and how patients receive medications from these pharmacies

A

specialty pharmacies receive specialty drugs from specialty distributors. Patients receive drugs by shipment

37
Q

describe the different specialty pharmacy models

A

Open distribution (manufacturer wants everyone to have access): many people have choices
Controlled distribution: (manufacturer wants to control access) lower cost less product access choice

38
Q

describe the services typically provided by specialty pharmacies vs HUBs

A

dispensing, quality of life screening, medication adherence, adverse drug reaction screening, clinical interventions, follow up, education, REMs

39
Q

explain the importance of accreditation of specialty pharmacies

A

drug manufacturers and payors want to work with the best specialty pharmacies, provides competitive advantage, fosters continual improvement, compliance with the law.
has become integral and MANDATORY part of the operational excellence.
URAC, Joint Commission, National Committee for Quality Assurance (NCQA)

40
Q

number of deaths in US associated with the 1918 H1N1 pandemic

A

675,000 (fewer died in US than worldwide)

41
Q

number of deaths in US to date (2023) associated with the COVID 19 pandemic)

A

1.1 million

42
Q

january 2022 covid was what leading cause of death in US

A

2nd

43
Q

which is associated with greatest risk of poor outcomes and death associated with COVID 19

A

advanced age, underlying respiratory disease, immunosuppression, obesity, underlying cardiovascular disease

44
Q

which of the following is associated most closely with willingness to get vaccine

A

political party